KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -25.9% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $27 | -53.4% | 15,000 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $58 | -65.9% | 15,000 | +175.2% | 0.00% | -66.7% |
| Q4 2022 | $170 | -99.9% | 5,450 | 0.0% | 0.01% | -43.8% |
| Q3 2022 | $274,000 | +21.2% | 5,450 | 0.0% | 0.02% | +33.3% |
| Q2 2022 | $226,000 | -38.6% | 5,450 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $368,000 | +161.0% | 5,450 | +2377.3% | 0.02% | +220.0% |
| Q4 2021 | $141,000 | -66.3% | 220 | -99.6% | 0.01% | -73.7% |
| Q3 2021 | $419,000 | +35.2% | 50,220 | +151.1% | 0.02% | +11.8% |
| Q4 2020 | $310,000 | +6.2% | 20,000 | 0.0% | 0.02% | -10.5% |
| Q3 2020 | $292,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |